Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending.

Ortiz Brugués, Ariadna; Sibaud, Vincent; Herbault-Barrés, Beatrice; Betrian, Sarah; Korakis, Iphigenie; De Bataille, Caroline; Gomez-Roca, Carlos; Epstein, Joel; Vigarios, Emmanuelle

Ortiz Brugués, Ariadna; Sibaud, Vincent; Herbault-Barrés, Beatrice; Betrian, Sarah; Korakis, Iphigenie; De Bataille, Caroline; Gomez-Roca, Carlos; Epstein, Joel; Vigarios, Emmanuelle.

Afiliação

Ortiz Brugués A; Hospital Santa Caterina, Girona, Spain.
Sibaud V; Department of Oncodermatology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Herbault-Barrés B; Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Betrian S; Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Korakis I; Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
De Bataille C; Department of Oral Medicine, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Gomez-Roca C; Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
Epstein J; Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA.
Vigarios E; Department of Oral Medicine, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.

Oncologist ; 25(2): e391-e395, 2020 02.

Article em En | MEDLINE | ID: mdl-32043780

Assuntos

Síndrome de Sjogren; Humanos; Imunoterapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google